𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

✍ Scribed by Ulrich F. H. Leuschner; Birgit Lindenthal; Günter Herrmann; Joachim C. Arnold; Martin Rössle; Hans-Jörg Cordes; Stefan Zeuzem; Jasper Hein; Thomas Berg; the NASH Study Group

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
165 KB
Volume
52
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of giant cell arteritis using
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial
✍ Mehrdad Mazlumzadeh; Gene G. Hunder; Kirk A. Easley; Kenneth T. Calamia; Eric L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract ## Objective Glucocorticoid (GC) therapy for giant cell arteritis (GCA) is effective but requires prolonged administration, resulting in adverse side effects. The goal of the current study was to test the hypothesis that induction treatment with high‐dose pulse intravenous (IV) methylp

Ursodeoxycholic acid as adjunctive thera
Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo-controlled treatment trial
✍ Albert J. Czaja; Herschel A. Carpenter; Keith D. Lindor 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

To evaluate the efficacy of ursodeoxycholic acid as adjunctive therapy in type 1 autoimmune hepatitis, 37 patients who had experienced treatment failure, repeated relapse, or incomplete response were randomized to ursodeoxycholic acid (13-15 mg/kg daily) or placebo for 6 months in addition to their

A randomised, double-blind, placebo-cont
A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia
✍ Adrian A. Barnett; J. Christoph Haller; Fiona Cairnduff; Geoffrey Lane; Stanley 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 67 KB

## Abstract Photodynamic therapy (PDT) using topical 5‐aminolaevulinic acid (ALA) has been used to treat histologically confirmed cervical intraepithelial neoplasia (CIN‐I and ‐I/II) in a randomised, double‐blind, placebo‐controlled protocol. Fluorescence microscopy revealed that topical applicatio

Combination therapy with thymosin α1 and
Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial
✍ Kenneth E. Sherman; Maria Sjogren; Robin L. Creager; Melissa A. Damiano; Stephen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Hepatitis C is a major cause of liver disease leading to cirrhosis. Although interferon (IFN) is the only approved therapy, treatment is characterized by low response rates and dose-limiting side effects. We evaluated the addition of thymosin ␣1 (TA1), an immunomodulatory peptide, to the standard tr

Efficacy and safety of high-dose pravast
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial
✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place